Search
Procept Biorobotics Corp
PRCTAdd to Watchlist
18.620USD
+0.620+3.44%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.06BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Procept Biorobotics Corp is 7.20, ranking 149 out of 199 in the Healthcare Equipment & Supplies industry. The average price target is 51.00, with a high of 75.00 and a low of 38.00.
Analyst Rating
Based on
15
analysts
Buy
Current Rating
30.333
Target Price
+62.91%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
Procept Biorobotics Corp
PRCT
15
Medtronic PLC
MDT
34
Stryker Corp
SYK
32
Dexcom Inc
DXCM
32
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
29
1
2
3
...
22
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Procept Biorobotics Corp's expected revenue for the next quarter?
Procept Biorobotics Corp's expected revenue is 92.89M.
What is Procept Biorobotics Corp's price target?
Analysts forecast that Procept Biorobotics Corp's price target is USD 51.00, with the highest forecast at USD 75.00 and the lowest forecast at USD 38.00.
How have Procept Biorobotics CorpPRCT's recent earnings per share performed?
The market expectation was USD -0.56, while Procept Biorobotics CorpPRCT's earnings per share (EPS) for the previous quarter was USD -0.53. EPS for the next quarter is expected at USD -0.46.
What is the analyst rating for Procept Biorobotics Corp?
Based on the ratings of Procept Biorobotics Corp's stock from 15 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.